- Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
-
Scherbak NN, Kruse R, Nyström T, Jendle J
- KMID: 2548165
- Diabetes Metab J.
- 2023 Nov;47(6):882-883.
- doi: 10.4093/dmj.2023.0355
-
- CITED
-
- Close
- SHARE
-
- Close
- Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
-
Scherbak NN, Kruse R, Nyström T, Jendle J
- KMID: 2546125
- Diabetes Metab J.
- 2023 Sep;47(5):668-681.
- doi: 10.4093/dmj.2022.0342
Background: Diabetes is a chronic disease with several long-term complications. Several glucose-lowering drugs are used to treat type 2 diabetes mellitus (T2DM), e.g., glimepiride and liraglutide, in which both having... -
- CITED
-
- Close
- SHARE
-
- Close
